Fox Chase Cancer Center Welcomes Dr. Alexander R. Vartanov

Vartanov 1200
Alexander R. Vartanov, MD, has joined Fox Chase Cancer Center as an Assistant Professor in the Department of Bone Marrow Transplant and Cellular Therapies.

PHILADELPHIA (September 13, 2024) — Fox Chase Cancer Center is pleased to announce the hiring of Alexander R. Vartanov, MD, as an Assistant Professor in the Department of Bone Marrow Transplant and Cellular Therapies. 

Vartanov is joining the department on the heels of his completion of the Fox Chase Hematology/Oncology Fellowship Training Program. Prior to that, he was a resident in internal medicine at the University of Connecticut School of Medicine. 

Vartanov earned his medical degree from the American University of the Caribbean School of Medicine and a Master of Applied Science degree, in which his work focused on spatial analysis for public health, from Johns Hopkins University. 

Since 2011, Vartanov has produced over 25 abstracts, poster presentations, and peer-reviewed publications. His work covers a variety of subject areas, including lymphoma and leukemia. He also held various clinical research positions at the Dana-Farber Cancer Institute in Boston prior to medical school. 

Vartanov is a member of the American Society of Hematology, the American Society of Clinical Oncology, and the American Society for Transplantation and Cellular Therapy. He is also the recipient of several awards, including the Abstract Achievement Award from the American Society of Hematology Annual Meeting in 2019. In 2022, he received an In Vino Vita Young Investigator Award from Fox Chase to further his research on the use of steroids in patients being treated for lymphoma.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text